ImmuPharma PLC
LSE:IMM
ImmuPharma PLC
LSE:IMM
Price:
6.64
GBX
-1.48%
Market Closed
Market Cap:
£33.4m
Cash Flow Statement
Cash Flow Statement
ImmuPharma PLC
ImmuPharma PLC
Currency: GBP
| Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Sep-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(3)
|
(7)
|
(8)
|
(8)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(7)
|
(5)
|
(3)
|
(3)
|
(3)
|
(3)
|
(2)
|
(4)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
1
|
1
|
2
|
2
|
1
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Cash Taxes Paid |
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(0)
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Cash from Operating Activities |
(3)
N/A
|
(4)
-38%
|
(4)
+6%
|
(5)
-13%
|
(4)
+5%
|
(4)
+6%
|
(3)
+29%
|
(3)
-11%
|
(4)
-7%
|
(3)
+3%
|
(5)
-40%
|
(5)
+1%
|
(2)
+51%
|
(1)
+42%
|
(1)
+1%
|
(2)
-16%
|
(2)
-11%
|
(2)
-7%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
(2)
|
(2)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
(0)
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-1 664%
|
(0)
-2%
|
(2)
-8 195%
|
(2)
+0%
|
(0)
+95%
|
(0)
+18%
|
(1)
-582%
|
(1)
-12%
|
(1)
+8%
|
(0)
+91%
|
0
N/A
|
(0)
N/A
|
(0)
0%
|
0
N/A
|
2
+784%
|
1
-23%
|
(0)
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
4
|
4
|
10
|
10
|
0
|
3
|
4
|
8
|
7
|
8
|
4
|
4
|
2
|
2
|
1
|
0
|
0
|
3
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
2
|
1
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
1
|
0
|
(1)
|
0
|
(2)
|
(3)
|
(1)
|
(0)
|
(1)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
1
|
(2)
|
|
| Cash from Financing Activities |
4
N/A
|
5
+21%
|
10
+89%
|
9
-10%
|
(0)
N/A
|
0
N/A
|
3
+855%
|
8
+169%
|
6
-30%
|
6
-1%
|
1
-88%
|
1
-16%
|
2
+163%
|
2
+2%
|
1
-54%
|
1
+15%
|
1
-40%
|
1
+179%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
|
| Net Change in Cash |
1
N/A
|
1
-32%
|
6
+590%
|
2
-63%
|
(7)
N/A
|
(4)
+48%
|
0
N/A
|
4
+888%
|
2
-66%
|
2
+17%
|
(4)
N/A
|
(4)
0%
|
(1)
+77%
|
0
N/A
|
(0)
N/A
|
1
N/A
|
0
-97%
|
(1)
N/A
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(3)
N/A
|
(4)
-39%
|
(4)
+6%
|
(5)
-15%
|
(5)
+5%
|
(4)
+5%
|
(3)
+27%
|
(4)
-16%
|
(4)
-5%
|
(4)
+4%
|
(5)
-31%
|
(5)
+2%
|
(2)
+49%
|
(1)
+40%
|
(1)
+8%
|
(2)
-16%
|
(2)
-12%
|
(2)
-7%
|
|
Switch to:
Switch to:
See Also
Discover More
